Nuclear apoptosis-inducing factor 1 (NAIF1) acts as an oncogene and involves in tumorigenesis in several cancers. However, the expression and mechanism of NAIF1 in osteosarcoma remains unclear. In this study, we demonstrated the downregulation of NAIF1 expression in both osteosarcoma tissues and cell lines. We next explored the potential role of NAIF1 in osteosarcoma cell proliferation and migration. The result showed that overexpression of NAIF1 evidently suppressed the cell proliferation and invasion of osteosarcoma. Furthermore, we investigated the potential mechanisms accounting for dysregulation of NAIF1 in osteosarcoma. The bioinformatic prediction and luciferase reporter assay revealed that miR-128 is a direct upstream regulator of NAIF1 and regulates NAIF1 expression by binding the 3′-UTR of NAIF1.
| INTRODUCTION
Osteosarcoma (OS) is the most common malignant bone tumour and the second leading cause of cancer-related death affecting children and adolescents. 1, 2 Despite the development of therapeutic strategies (including surgery and multiagent chemotherapy), the survival rate for metastatic OS remains at 20% for the past 30 years. 3, 4 Therefore, identification of biomarkers and revealing the underlying molecular mechanism of OS are critical for OS diagnosis and treatment.
The human gene encoding nuclear apoptosis-inducing factor 1 (NAIF1) is located on chromosome 9q34.11, and reported to repress the progression of several human cancers. 5, 6 NAIF1 was downregulated or lost in gastric cancer tissues, plays an inhibitory role in the initial steps of gastric cancer genesis. 6, 7 Fu et al showed that overexpression of NAIF1 had an antitumor effect on prostate cancer cell proliferation and migration. 5 NAIF1 expression level in NSCLC tissues was suppressed, and restoration of NAIF1 in lung cancer cell inhibited cell proliferation and anchorage-independent survival ability. 8 However, the expression and role of NAIF1 in OS remains elusive.
MicroRNA (miRNA) is an abundant group of small noncoding RNA (with about 22 nucleotides). It controls expression of target gene by binding to the 3′ untranslated region (UTR) of their target mRNAs and plays an important role in a variety of biological processes including cell proliferation, apoptosis, differentiation, invasion, migration, and so on. [9] [10] [11] [12] Accumulating studies showed that miRNAs are dysregulated in a variety of cancers and play a critical role in tumorigenesis. [13] [14] [15] [16] [17] [18] Recent studies demonstrated that miRNAs have been recognized as critical regulators in development and progression of cancer including OS. 19, 20 In this study, we first time revealed the deregulated expression of NAIF1 in OS and investigated the function of NAIF1 on OS cell proliferation and invasion. Furthermore, we identified miR-128 as upstream regulator of NAIF1 to involve the progression of OS. In conclusion, NAIF1 acts as a tumour suppressor and may serve as a potential therapeutic target in OS. Prism 7300 System, with GAPDH as internal control. 21, 22 The specific primers used for the PCR reaction were as follows: NAIF1, 5′ GGCC CAATGGAATCAGCTACAG-3′ (forward) and 5′-GAAGAAACTGCTTG ATTCTTCG-3′ (reverse); GAPDH, 5′ATGTCGTGGAGTCTACTGGC-3′
(forward) and 5′-TGACCTTGCCCACAGCCTTG-3′ (reverse).
| Luciferase reporter gene assays
The 3′-UTR of NAIF1 was amplifies to pGL3 luciferase promoter vector (53711-5399, Promega, Madison, WI, USA) as previously 
| Western blotting analysis

| Cell proliferation assay
The 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was adopted to assess cell viability as described previously. 24 
| Cell migration assay
The cell migration ability was examined by wound healing assay as described previously. 25 Briefly, 1 × 10 5 MG-63 and U2OS cells were plated in 6-well plate at 37°C for 24 hours. And then, we used a sterilized tip drawn a line lightly. The cells incubation at 37°C for 24 hours; then, cells were put into serum-free medium for photographing with
Olympus Inverted Microscope (Olympus Optical Co., Ltd., Tokyo, Japan). All the experiments were repeated in triplicate, and the relative migration ratio was calculated through detecting the relative ratio to the untreated control cell group.
| Statistical analysis
Each experiment was repeated at least three times. Data were shown as mean ± SD and analysed using SPSS 19.0. Statistical comparisons between groups were analysed using Student's t test, and a two-tailed P < 0.05 was considered to indicate statistical significance. A paired t test was used for the paired data analyses. Bonferroni method was used in multiple comparison that was conducted.
3 | RESULTS
| NAIF1 expression in both osteosarcoma tissues and cell lines
NAIF1 was reported to be downregulated and functions as oncogene in several human cancers. 5, 6 To reveal the potential role of NAIF1 in OS, we detected the expression levels of NAIF1 in 30 OS specimens and paired normal bone tissue (NT). As shown in Figure 1A , significantly lower levels of NAIF1 were detected by RT-qPCR in the OS samples, compared with those in normal bone tissue (P = 0.013). Next, we detected the expression of NAIF1 in OS cell lines (MG-63 and U2OS) and human normal osteoblast cell line NHOst. We found that NAIF1 expression in OS cell lines (MG-63 and U2OS) was much lower than that in the human normal osteoblast cell line NHOst (P = 0.021 and P = 0.012, Figure 1B ).
| NAIF1 in osteosarcoma proliferation and migration
In order to understand the molecular basis of these findings, we analysed the role of NAIF1 on OS proliferation and migration. We used MG-63 and U2OS cell lines to transfect with pcDNA-NAIF1 to overexpress NAIF1 in OS cells. Next, alteration of NAIF1 levels in these cells was confirmed by quantitative real-time polymerase chain reaction (qRT-PCR) (P < 0.001, Figure 2A) . We analysed the role of NAIF1 on cell proliferation ability and migration ability. As shown in Figure 2B and 2C, cell proliferation ability was evidently repressed in pcDNA-NAIF1 group in both MG-63 and U2OS cells (P = 0.038 and P 0.045 in 48 hours and P = 0.012 and P = 0.021 in 72 hours). These data demonstrate that NAIF1 may repress OS cell growth in OS. As showed in Figure 2D and 2E, the wound healing assay showed that cell migration ability was evidently decreased in pcDNA-NAIF1 group, indicating that NAIF1 may repress OS cell migration in OS (P = 0.025 and P = 0.032). In conclusion, these results indicated that NAIF1 may function as a tumour suppressor and repressed tumorigenesis in OS.
| NAIF1 is a direct target gene of miR-128 in OS
Previous studies showed that miRNAs play important role in tumour progression by repressing its target gene at its 3′-UTR. So, we performed bioinformatic analysis to predict the upstream regulator of NAIF1 in OS. In this study, TargetScan was used to predict the putative targets of miR-128 (http://www.targetscan.org/). As shown in Figure 3 A, miR-128 could direct target the 3′-UTR of the NAIF1. We next contransfected miR-128 mimics and NAIF1-WT or NAIF1-Mut into HEK293 cell and analysed the luciferase activity a dual luciferase reporter assay. We found that miR-128 mimics evidently repressed qRT-PCR and western blot. As shown in Figure 3C and 3D, both mRNA and protein expression levels of NAIF1 were significantly downregulated by miR-128 mimics in OS cells (MG-63 and U2OS).
| miR-128 promotes OS progression by inhibiting NAIF1 expression
Previous studies showed controversial point on the expression of miR-128 in OS. Liu et al showed that miR-128 expression was downregulated in osteosarcoma tissues and OS cell lines, 26 but Shen et al revealed upregulated miR-128 in OS tissues compared with adjacent normal tissues. 27 To further confirm the expression levels of miR-128 in OS, we detected the miR-128 expression in both OS tissues on OS proliferation and migration. As shown in Figure 4C and 4D, miR-128 inhibitors evidently suppressed osteosarcoma cell proliferation and migration, which was rescued by NAIF1 siRNA. In conclusion, these results indicated that miR-128 promotes OS progression by repressing NAIF1 expression. However, it should be noted that the expression of NAIF1 expression in the miR-128 inhibitor and siNAIF1 group was not detected, and it is unclear if NAIF1 levels had returned to control level. Even though the results in these points were quite robust, it should also be considered in the lack of NAIF1 expression data.
| DISCUSSION
The underlying mechanism of OS carcinogenesis is critical for predicting prognosis and developing therapeutic strategy. Therefore, it is urgent to investigate the potential molecule mechanism of osteosarcoma progression. In the present study, we indicated NAIF1, as a tumour suppressor, regulated by miR-128, involving OS progression by repressing cell proliferation and migration.
NAIF1 functions as an tumour suppressor and represses tumour progression of several human cancers, 5, 6 including gastric cancer genesis, 6, 7 prostate cancer, 5 and NSCLC. 8 However, the expression and role of NAIF1 in OS remains unclear. In this study, we revealed the upregulation of NAIF1 expression in OS tissues and cell lines. Furthermore, pcDNA-NAIF1 was used to overexpress NAIF1 expression in FIGURE 4 miR-128 promotes OS proliferation and migration by inhibiting NAIF1 expression. A, Expression levels of miR-128 in 30 OS specimens and paired normal bone tissue. B, miR-128 expression in OS cell lines. C, Effect of miR-128 on cell proliferation assay in MG-63. D, Effect of miR-128 on cell proliferation assay in U2OS. E, Effect of miR-128 on cell migration assay in MG-63. F, Effect of miR-128 on cell migration assay in U2OS. Data are presented as means ± SD from three independent experiments. *P < 0.05 vs control group, *P < 0.05 vs control group, and ***P < 0.001 vs control group both MG-63 and U2OS cell and found that overexpressed NAIF1 may repress OS cell proliferation and migration in OS. promotes OS progression by inhibiting NAIF1 expression.
In conclusion, this study showed for the first time that NAIF1 was downregulated in OS tissue and cell lines. We also demonstrated that NAIF1 can suppress the proliferation and invasion of OS cells.
Furthermore, we also showed miR-24 as oncogenic effects by negatively regulating NAIF1 expression in OS, revealing a new avenue for treatment of OS.
